Complete Dose Comparison: Your Journey From Start to Maintenance
Is Wegovy or Mounjaro Better: Complete Dose Range Analysis
When evaluating whether Wegovy or Mounjaro is better for your weight management journey, having access to every dose from a single pharmacy eliminates the uncertainty of switching suppliers mid-treatment. Wegovy follows a structured five-dose escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance from week 17 onwards. Mounjaro uses a similar tiered approach but with different dose strengths, making direct comparison essential for long-term planning. EverydayMeds stocks every dose of both medications, ensuring seamless progression throughout your entire treatment pathway without supply interruptions.
The question of whether Wegovy or Mounjaro is better often depends on individual response to dose escalation and maintenance requirements. Wegovy's 2.4mg maintenance dose represents the standard maximum for most patients, while Mounjaro's dosing flexibility may suit different metabolic profiles. Having assured access to all doses means your prescriber can adjust your treatment based on tolerance and effectiveness rather than pharmacy availability. This comprehensive approach transforms your weight management journey from a series of uncertain supply decisions into a predictable, supported progression.
Wegovy vs Mounjaro Pricing: All Doses Available
Understanding the complete cost structure helps answer whether Wegovy or Mounjaro is better for your budget across the entire treatment duration. Wegovy pricing at EverydayMeds starts with the 0.25mg dose at £79.99, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout, while returning patients use code DOSE25 to access these final prices. Our bundle options provide convenience advantages: the Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first 12 weeks with one order.
Long-term maintenance planning becomes clearer when comparing whether Wegovy or Mounjaro is better value once you reach stable dosing. The Ultimate Stability Trio provides three months of 2.4mg Wegovy for £649.99, ensuring uninterrupted maintenance supply. Consistency bundles offer two pens of the same dose, such as the Consistency 1mg bundle at £209.99, perfect for patients who need extended time at specific dose levels. This comprehensive pricing structure means you can budget accurately from treatment initiation through long-term maintenance, regardless of which option your prescriber determines is most suitable.
Clinical Evidence: Is Wegovy or Mounjaro Better Based on Trials?
Both medications demonstrate significant efficacy in clinical trials, though direct comparison requires understanding their different mechanisms and trial designs. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks in STEP 1, with sustained results of 15.2% at 2 years in STEP 5. The SELECT trial additionally showed a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
When considering whether Wegovy or Mounjaro is better, it's important to note that Mounjaro's SURMOUNT trials used different endpoints and patient populations, making direct percentage comparisons inappropriate. Both medications require dose escalation and long-term commitment, with weight regain observed when treatment discontinues. Your prescriber will evaluate your medical history, comorbidities, and individual risk factors to determine which option aligns best with your health profile rather than relying solely on trial averages.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to support weight management alongside a reduced-calorie diet and increased physical activity. The medication works by binding to GLP-1 receptors in your brain's appetite centres, promoting feelings of satiety after smaller meals and potentially reducing food cravings between meals. This mechanism develops gradually through dose escalation, which is why starting at 0.25mg and progressing to 2.4mg over 16 weeks allows your body to adapt while minimising gastrointestinal side effects. Unlike Mounjaro, which targets both GIP and GLP-1 receptors as a dual agonist, Wegovy focuses specifically on GLP-1 pathways. The once-weekly injection maintains consistent hormone levels throughout the week, supporting sustained appetite regulation rather than requiring daily medication adherence.
Ordering Process: From Assessment to All Doses Delivered
EverydayMeds streamlines access to every Wegovy dose through a comprehensive ordering process designed for long-term treatment success. The initial 3-minute online clinical assessment covers your entire weight management journey, not just the first prescription, allowing future dose escalations without repeated lengthy evaluations. Our prescribers review applications within 3 working days (or 24 hours with express service), considering your BMI, medical history, and suitability for the complete dose range from 0.25mg through 2.4mg maintenance. Once approved, all orders benefit from next-day delivery using cold-chain temperature-controlled packaging to maintain medication integrity. The GPhC-registered pharmacy service (#9012878) ensures regulatory compliance and clinical oversight throughout your treatment, whether you need single pens, convenience bundles, or maintenance supply planning. This integrated approach means one assessment unlocks access to your complete treatment pathway without administrative barriers.
Storage and Practical Considerations: Wegovy vs Mounjaro Differences
Storage requirements significantly impact daily life and travel plans when determining whether Wegovy or Mounjaro is better for your lifestyle. Wegovy pens must be stored in the fridge at 2-8°C before first use but can remain at room temperature below 30°C for up to 6 weeks once removed from refrigeration, providing substantial travel flexibility compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen design requires no mixing or preparation, with dose selection automatically set for each escalation stage from 0.25mg to 2.4mg. Injection timing remains consistent once weekly, allowing you to choose the same day each week regardless of dose strength. Dose escalation cannot be skipped or accelerated, making the structured progression from starter to maintenance doses a mandatory 16-week timeline. Having all doses available from one pharmacy eliminates concerns about pen compatibility or injection technique changes between suppliers.
Complete Treatment Journey: Why All Doses Available Matters
The advantage of having every Wegovy dose available becomes apparent during the critical transition periods between dose escalations and when individualised adjustments are necessary. Some patients require extended time at specific doses, particularly at 1mg or 1.7mg levels, before progressing to maintenance therapy, making reliable supply of all strengths essential for treatment success. Others may need to return to lower doses temporarily if side effects occur, requiring immediate access to previously used strengths without treatment interruption.
This comprehensive availability transforms the question of whether Wegovy or Mounjaro is better from a single decision into an ongoing partnership with your healthcare provider and pharmacy. EverydayMeds' complete stock range means your treatment can be optimised based on individual response rather than restricted by supply limitations. The ability to order maintenance supplies, dose escalation bundles, or individual pens as needed provides flexibility that supports long-term adherence and treatment success beyond the initial prescription decision.
Expert Consultation: Making Your Decision With Professional Support
Rather than determining whether Wegovy or Mounjaro is better in isolation, EverydayMeds provides access to both options through expert clinical assessment and ongoing prescriber support. Our clinical team evaluates factors including your BMI, existing health conditions, medication interactions, and lifestyle requirements to recommend the most suitable treatment option. The comprehensive dose availability means this recommendation isn't limited by supply constraints, allowing purely clinical decision-making. With both medications available from £79.99 and complete dose ranges in stock, your prescriber can focus on medical suitability rather than practical availability when guiding your choice. Apply codes FIRST40 (new customers) or DOSE25 (returning patients) at checkout to access our complete Wegovy range at https://everydaymeds.co.uk/collections/wegovy, where expert clinical support continues throughout your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
